CNOT1

Chr 16AD

CCR4-NOT transcription complex subunit 1

Also known as: AD-005, CDC39, HPE12, NOT1, NOT1H, VIBOS

Enables armadillo repeat domain binding activity; molecular adaptor activity; and nuclear receptor binding activity. Contributes to poly(A)-specific ribonuclease activity. Involved in several processes, including negative regulation of intracellular signal transduction; positive regulation of cytoplasmic mRNA processing body assembly; and regulation of gene expression. Located in P-body and cytosol. Part of CCR4-NOT complex. Implicated in Vissers-Bodmer syndrome and holoprosencephaly 12. [provided by Alliance of Genome Resources, Jul 2025]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.042 OMIM phenotypes
Clinical SummaryCNOT1
🧬
Gene-Disease Validity (ClinGen)
holoprosencephaly 12 with or without pancreatic agenesis · ADLimited

Limited evidence — not for standalone diagnostic reporting

2 total gene-disease associations curated

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
47 unique Pathogenic / Likely Pathogenic· 460 VUS of 953 total submissions
📖
GeneReview available — CNOT1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.04LOEUF
pLI 1.000
Z-score 10.28
OE 0.01 (0.000.04)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
7.25Z-score
OE missense 0.43 (0.400.46)
561 obs / 1295.9 exp
Constrained

Extremely missense-constrained (top ~0.01%)

Observed / Expected Ratios?
LoF OE?0.01 (0.000.04)
00.351.4
Missense OE?0.43 (0.400.46)
00.61.4
Synonymous OE?1.03
01.21.6
LoF obs/exp: 1 / 125.0Missense obs/exp: 561 / 1295.9Syn Z: -0.51
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongCNOT1-related neurodevelopmental disorderOTHERAD
strongCNOT1-related holoprosencephaly with or without pancreatic agenesisOTHERAD

This gene — mechanism propensity

DN
0.2099th %ile
GOF
0.3193th %ile
LOF
0.82top 5%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 81% of P/LP variants are LoF · LOEUF 0.04 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Literature Evidence

LOFAn integrated omics approach of patient-derived genomics and transcriptomics data suggested only minimal effects on endonucleolytic nonsense-mediated mRNA decay components, suggesting that de novo CNOT1 variants are likely haploinsufficient hypomorph or neomorph, rather than dominant negative.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 32553196

ClinVar Variant Classifications

953 submitted variants in ClinVar

Classification Summary

Pathogenic18
Likely Pathogenic29
VUS460
Likely Benign275
Benign104
Conflicting11
18
Pathogenic
29
Likely Pathogenic
460
VUS
275
Likely Benign
104
Benign
11
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
14
4
0
0
18
Likely Pathogenic
24
4
1
0
29
VUS
11
417
25
7
460
Likely Benign
2
15
110
148
275
Benign
3
2
82
17
104
Conflicting
11
Total54442218172897

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

24 pathogenic / likely-pathogenic (of 35) ClinVar copy-number / structural variants overlap CNOT1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CNOT1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →